MRC1 and endometrium neoplasm: Hampel and colleagues found all 6 endometrial tumours from path_MSH6 carriers were MMR deficient, but just 3/6 were MSI-H; despite this, tumours were triaged for MMR germline sequencing using the results of MSI analysis, and only a subset underwent MMR-IHC [8].